{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:32:34Z","timestamp":1792787554214,"version":"4.5.0"},"reference-count":247,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Huntingto\u0144s Society of Canada","id":[{"id":"https:\/\/ror.org\/01mahh263","id-type":"ROR","asserted-by":"crossref"}]},{"name":"CNPq and FAPEMIG"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.phrs.2016.11.013","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T01:45:28Z","timestamp":1479519928000},"page":"179-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":251,"special_numbering":"C","title":["Metabotropic glutamate receptors and neurodegenerative diseases"],"prefix":"10.1016","volume":"115","author":[{"given":"Fabiola M.","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciene B.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita G.W.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roenick P.","family":"Olmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.G.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0005","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/pr.108.000166","article-title":"Metabotropic glutamate 1 receptor: current concepts and perspectives","volume":"60","author":"Ferraguti","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2016.11.013_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.bb.23.060194.001535","article-title":"Molecular diversity and functions of glutamate receptors","volume":"23","author":"Nakanishi","year":"1994","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0163-7258(03)00038-X","article-title":"Evolution, structure, and activation mechanism of family 3\/C G-protein-coupled receptors","volume":"98","author":"Pin","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.11.013_bib0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu. Rev. Pharmacool. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coph.2006.08.008","article-title":"Metabotropic glutamate receptors: intracellular signaling pathways","volume":"7","author":"Gerber","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-010-8153-1","article-title":"Huntington's disease and Group I metabotropic glutamate receptors","volume":"43","author":"Ribeiro","year":"2011","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pharmthera.2011.01.006","article-title":"Dimers and beyond: the functional puzzles of class C GPCRs","volume":"130","author":"Kniazeff","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","article-title":"The metabotropic glutamate receptors: structure and functions","volume":"34","author":"Pin","year":"1995","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0050","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1152\/jn.1996.76.4.2691","article-title":"Metabotropic glutamate receptors coupled to IP3 production mediate inhibition of IAHP in rat dentate granule neurons","volume":"76","author":"Abdul-Ghani","year":"1996","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pharmthera.2005.01.008","article-title":"Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis","volume":"111","author":"Dhami","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)29296-X","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(93)90227-C","article-title":"Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain","volume":"163","author":"Shigemoto","year":"1993","journal-title":"Neurosci. Lett."},{"issue":"19","key":"10.1016\/j.phrs.2016.11.013_bib0070","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1523\/JNEUROSCI.17-19-07503.1997","article-title":"Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus","volume":"17","author":"Shigemoto","year":"1997","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0075","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0896-6273(93)90086-7","article-title":"The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction","volume":"11","author":"Baude","year":"1993","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.phrs.2016.11.013_bib0080","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1460-9568.1996.tb01611.x","article-title":"Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus","volume":"8","author":"Lujan","year":"1996","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0896-6273(92)90165-A","article-title":"Cellular localization of a metabotropic glutamate receptor in rat brain","volume":"9","author":"Martin","year":"1992","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cne.903220110","article-title":"Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat","volume":"322","author":"Shigemoto","year":"1992","journal-title":"J. Comp. Neurol."},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib0095","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1523\/JNEUROSCI.21-06-01838.2001","article-title":"Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey Substantia nigra","volume":"21","author":"Hubert","year":"2001","journal-title":"J. Neurosc.: Off. J. Soc. Neurosci."},{"issue":"19","key":"10.1016\/j.phrs.2016.11.013_bib0100","doi-asserted-by":"crossref","first-page":"13361","DOI":"10.1016\/S0021-9258(18)42219-3","article-title":"Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate\/Ca2+ signal transduction","volume":"267","author":"Abe","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cne.903550310","article-title":"Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain","volume":"355","author":"Romano","year":"1995","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00001756-199412300-00053","article-title":"Cellular and subcellular localization of the mGluR5a metabotropic glutamate receptor in rat spinal cord","volume":"6","author":"Vidnyanszky","year":"1994","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0165-3806(98)00156-4","article-title":"Distribution and developmental changes in metabotropic glutamate receptor messenger RNA expression in the rat lumbar spinal cord, brain research","volume":"112","author":"Berthele","year":"1999","journal-title":"Dev. Brain Res."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/(SICI)1096-9861(19990809)410:4<627::AID-CNE9>3.0.CO;2-8","article-title":"Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn","volume":"410","author":"Jia","year":"1999","journal-title":"J. Comp. Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0125","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0306-4522(93)90485-X","article-title":"Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat","volume":"53","author":"Ohishi","year":"1993","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0896-6273(94)90459-6","article-title":"Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex","volume":"13","author":"Ohishi","year":"1994","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0135","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cne.903350209","article-title":"Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study","volume":"335","author":"Ohishi","year":"1993","journal-title":"J. Comp. Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0140","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1523\/JNEUROSCI.13-04-01372.1993","article-title":"Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4","volume":"13","author":"Tanabe","year":"1993","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"Pt. 2 (5)","key":"10.1016\/j.phrs.2016.11.013_bib0145","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1523\/JNEUROSCI.14-05-03005.1994","article-title":"Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat","volume":"14","author":"Testa","year":"1994","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0150","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0306-4522(95)00533-1","article-title":"The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations","volume":"71","author":"Petralia","year":"1996","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0155","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-4522(01)00305-0","article-title":"Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites","volume":"106","author":"Tamaru","year":"2001","journal-title":"Neuroscience"},{"issue":"16","key":"10.1016\/j.phrs.2016.11.013_bib0160","doi-asserted-by":"crossref","first-page":"11868","DOI":"10.1016\/S0021-9258(19)50280-0","article-title":"Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate","volume":"268","author":"Nakajima","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0165","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/(SICI)1096-9861(19980413)393:3<332::AID-CNE6>3.0.CO;2-2","article-title":"Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study","volume":"393","author":"Kinoshita","year":"1998","journal-title":"J. Comp. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(96)12519-2","article-title":"Presynaptic localization of a metabotropic glutamate receptor, mGluR4a, in the cerebellar cortex: a light and electron microscope study in the rat","volume":"207","author":"Kinoshita","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2016.11.013_bib0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0169-328X(94)90259-3","article-title":"Differential expression of metabotropic glutamate receptors in the hippocampus and entorhinal cortex of the rat, Brain research","volume":"21","author":"Fotuhi","year":"1994","journal-title":"Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0169-328X(96)00037-X","article-title":"Molecular characterization and localization of human metabotropic glutamate receptor type 3, brain research","volume":"40","author":"Makoff","year":"1996","journal-title":"Mol. Brain Res."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0185","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/1096-9861(20010219)430:4<448::AID-CNE1042>3.0.CO;2-O","article-title":"Immunoreactivity for the group III metabotropic glutamate receptor subtype mGluR4a in the superficial laminae of the rat spinal dorsal horn","volume":"430","author":"Azkue","year":"2001","journal-title":"J. Comp. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0306-4522(01)00591-7","article-title":"Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS","volume":"110","author":"Corti","year":"2002","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0195","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1523\/JNEUROSCI.15-04-03075.1995","article-title":"A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb","volume":"15","author":"Duvoisin","year":"1995","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/mol.51.1.119","article-title":"Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile","volume":"51","author":"Saugstad","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"12","key":"10.1016\/j.phrs.2016.11.013_bib0205","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1046\/j.1460-9568.1998.00371.x","article-title":"Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8","volume":"10","author":"Corti","year":"1998","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(99)00484-X","article-title":"Metabotropic glutamate receptors 2 and 3 expressed by astrocytes in rat ventrobasal thalamus","volume":"270","author":"Mineff","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.phrs.2016.11.013_bib0215","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1023\/A:1027317319166","article-title":"Metabotropic glutamate receptor expression in cultured rat astrocytes and human gliomas","volume":"22","author":"Condorelli","year":"1997","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0220","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1471-4159.1999.721671.x","article-title":"Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia","volume":"72","author":"Biber","year":"1999","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0225","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<533::AID-JNR6>3.0.CO;2-G","article-title":"mGluR3 and mGluR5 are the predominant metabotropic glutamate receptor mRNAs expressed in hippocampal astrocytes acutely isolated from young rats","volume":"58","author":"Schools","year":"1999","journal-title":"J. Neurosci. Res."},{"issue":"7","key":"10.1016\/j.phrs.2016.11.013_bib0230","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1046\/j.1460-9568.2000.00131.x","article-title":"Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy","volume":"12","author":"Aronica","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002210000633","article-title":"Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2\/3 and 5","volume":"137","author":"Ferraguti","year":"2001","journal-title":"Exp. Brain Res."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0240","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pain.2003.09.017","article-title":"Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia","volume":"106","author":"Dolan","year":"2003","journal-title":"Pain"},{"issue":"2\u20133","key":"10.1016\/j.phrs.2016.11.013_bib0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(99)00145-7","article-title":"Group I and II metabotropic glutamate receptor expression in cultured rat spinal cord astrocytes","volume":"263","author":"Silva","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"13","key":"10.1016\/j.phrs.2016.11.013_bib0250","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1523\/JNEUROSCI.22-13-05403.2002","article-title":"Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures","volume":"22","author":"Besong","year":"2002","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0255","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/(SICI)1098-1136(199712)21:4<390::AID-GLIA6>3.0.CO;2-7","article-title":"Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and \u22125 on astrocyte proliferation in culture","volume":"21","author":"Ciccarelli","year":"1997","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib0260","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1523\/JNEUROSCI.23-06-02150.2003","article-title":"Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity","volume":"23","author":"Taylor","year":"2003","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.013_bib0265","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1523\/JNEUROSCI.4456-04.2005","article-title":"Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand","volume":"25","author":"Taylor","year":"2005","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib0270","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1471-4159.2002.01062.x","article-title":"Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease","volume":"82","author":"Taylor","year":"2002","journal-title":"J. Neurochem."},{"issue":"36","key":"10.1016\/j.phrs.2016.11.013_bib0275","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"Pt. 3","key":"10.1016\/j.phrs.2016.11.013_bib0280","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3590465","article-title":"Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors","volume":"359","author":"Hermans","year":"2001","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0285","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/7243","article-title":"G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors","volume":"2","author":"Lu","year":"1999","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0290","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/6338","article-title":"Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems","volume":"2","author":"Alagarsamy","year":"1999","journal-title":"Nat. Neurosci."},{"issue":"13","key":"10.1016\/j.phrs.2016.11.013_bib0295","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1523\/JNEUROSCI.22-13-05452.2002","article-title":"Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2\/Src-family kinase pathway in cortical neurons","volume":"22","author":"Heidinger","year":"2002","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0300","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0896-6273(00)80589-9","article-title":"Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors","volume":"21","author":"Tu","year":"1998","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0305","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(00)80810-7","article-title":"Coupling of mGluR\/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins","volume":"23","author":"Tu","year":"1999","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.phrs.2016.11.013_bib0310","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/76615","article-title":"Proteomic analysis of NMDA receptor-adhesion protein signaling complexes","volume":"3","author":"Husi","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.013_bib0315","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/nn1134","article-title":"PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis","volume":"6","author":"Rong","year":"2003","journal-title":"Nat. Neurosci."},{"issue":"28","key":"10.1016\/j.phrs.2016.11.013_bib0320","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1523\/JNEUROSCI.0995-04.2004","article-title":"Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression","volume":"24","author":"Hou","year":"2004","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2016.11.013_bib0325","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1523\/JNEUROSCI.4360-04.2005","article-title":"The scaffold protein Homer1b\/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons","volume":"25","author":"Mao","year":"2005","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2016.11.013_bib0330","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1756-6606-3-4","article-title":"Pyk2 uncouples metabotropic glutamate receptor G protein signaling but facilitates ERK1\/2 activation","volume":"3","author":"Nicodemo","year":"2010","journal-title":"Mol. brain"},{"issue":"10","key":"10.1016\/j.phrs.2016.11.013_bib0335","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2174\/156802606777323700","article-title":"Trophic effect of glutamate","volume":"6","author":"Balazs","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2016.11.013_bib0340","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0169-328X(01)00217-0","article-title":"Group I metabotropic glutamate receptor activation increases phosphorylation of cAMP response element-binding protein, Elk-1, and extracellular signal-regulated kinases in rat dorsal striatum, Brain research","volume":"94","author":"Choe","year":"2001","journal-title":"Mol. Brain Research"},{"issue":"9","key":"10.1016\/j.phrs.2016.11.013_bib0345","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1523\/JNEUROSCI.15-09-06103.1995","article-title":"Growth factor upregulation of a phosphoinositide-coupled metabotropic glutamate receptor in cortical astrocytes","volume":"15","author":"Miller","year":"1995","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"20","key":"10.1016\/j.phrs.2016.11.013_bib0350","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1523\/JNEUROSCI.17-20-07817.1997","article-title":"Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ","volume":"17","author":"Pasti","year":"1997","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2016.11.013_bib0355","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-6606-6-9","article-title":"Role of metabotropic glutamate receptor 5 signaling and homer in oxygen glucose deprivation-mediated astrocyte apoptosis","volume":"6","author":"Paquet","year":"2013","journal-title":"Mol. Brain"},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0360","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1046\/j.1471-4159.1999.721441.x","article-title":"Group I metabotropic glutamate receptors mediate phospholipase D stimulation in rat cultured astrocytes","volume":"72","author":"Servitja","year":"1999","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0365","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1471-4159.1998.71020603.x","article-title":"Phosphorylation of mitogen-activated protein kinase in cultured rat cortical glia by stimulation of metabotropic glutamate receptors","volume":"71","author":"Peavy","year":"1998","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib0370","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/glia.20783","article-title":"Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity","volume":"57","author":"Byrnes","year":"2009","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0375","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1085\/jgp.109.4.477","article-title":"Positive and negative coupling of the metabotropic glutamate receptors to a G protein-activated K+ channel, GIRK, in Xenopus oocytes","volume":"109","author":"Sharon","year":"1997","journal-title":"J. Gen. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0380","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1471-4159.2002.00929.x","article-title":"Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase\/phosphatidylinositol-3-kinase pathways","volume":"82","author":"Iacovelli","year":"2002","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib0385","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1046\/j.1460-9568.1999.00626.x","article-title":"Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors","volume":"11","author":"Ferraguti","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"16","key":"10.1016\/j.phrs.2016.11.013_bib0390","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1523\/JNEUROSCI.0118-06.2006","article-title":"Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism","volume":"26","author":"Jiang","year":"2006","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"13","key":"10.1016\/j.phrs.2016.11.013_bib0395","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1074\/jbc.M111.325175","article-title":"Regulation of N-methyl-D-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7","volume":"287","author":"Gu","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.phrs.2016.11.013_bib0400","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1523\/JNEUROSCI.18-23-09594.1998","article-title":"Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta","volume":"18","author":"Bruno","year":"1998","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0405","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1471-4159.2001.00435.x","article-title":"Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways","volume":"78","author":"D'Onofrio","year":"2001","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.phrs.2016.11.013_bib0410","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1046\/j.1460-9568.2003.02657.x","article-title":"Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins","volume":"17","author":"Aronica","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib0415","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1124\/mol.106.031617","article-title":"Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen\/glucose deprivation in cultured astrocytes","volume":"71","author":"Ciccarelli","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0420","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/(SICI)1098-1136(19990101)25:1<93::AID-GLIA9>3.0.CO;2-N","article-title":"Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia\/hypoglycemia","volume":"25","author":"Ciccarelli","year":"1999","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0425","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1471-4159.2001.00056.x","article-title":"Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction","volume":"76","author":"Matarredona","year":"2001","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib0430","doi-asserted-by":"crossref","first-page":"e6591","DOI":"10.1371\/journal.pone.0006591","article-title":"Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons","volume":"4","author":"Battaglia","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0435","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0306-4522(02)00232-4","article-title":"DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury","volume":"113","author":"Venero","year":"2002","journal-title":"Neuroscience"},{"issue":"5800","key":"10.1016\/j.phrs.2016.11.013_bib0440","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0445","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.jalz.2014.02.001","article-title":"2014 Alzheimer's disease facts and figures","volume":"10","author":"Alzheimer's","year":"2014","journal-title":"Alzheimer's Dementia: J. Alzheimer's Assoc."},{"issue":"7113","key":"10.1016\/j.phrs.2016.11.013_bib0450","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nature05289","article-title":"A network dysfunction perspective on neurodegenerative diseases","volume":"443","author":"Palop","year":"2006","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.phrs.2016.11.013_bib0455","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease","volume":"16","author":"Gomez-Isla","year":"1996","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0460","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.phrs.2016.11.013_bib0465","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"3","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.013_bib0470","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","article-title":"Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels","volume":"4","author":"Masters","year":"1985","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.013_bib0475","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0962-8924(98)01363-4","article-title":"The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease","volume":"8","author":"Selkoe","year":"1998","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.phrs.2016.11.013_bib0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer's disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol. Brain"},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib0485","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jmb.2006.09.046","article-title":"Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity","volume":"364","author":"Yan","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"5054","key":"10.1016\/j.phrs.2016.11.013_bib0490","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.phrs.2016.11.013_bib0495","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","article-title":"Toward a comprehensive theory for Alzheimer's disease. Hypothesis: alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"924","author":"Selkoe","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.013_bib0500","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib0505","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers \u2212 a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J. Neurochem."},{"issue":"5669","key":"10.1016\/j.phrs.2016.11.013_bib0510","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease","volume":"304","author":"Lustbader","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0515","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1113\/jphysiol.2013.257527","article-title":"Calcium regulation of neural rhythms, memory and Alzheimer's disease","volume":"592","author":"Berridge","year":"2014","journal-title":"J. Physiol."},{"issue":"17","key":"10.1016\/j.phrs.2016.11.013_bib0520","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","article-title":"Calcium signaling and amyloid toxicity in Alzheimer disease","volume":"285","author":"Demuro","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0525","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0006-291X(02)00346-7","article-title":"Mechanism of membrane depolarization caused by the Alzheimer Abeta1-42 peptide","volume":"293","author":"Blanchard","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0530","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4067\/S0716-97602005000400011","article-title":"Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation","volume":"38","author":"Roth","year":"2005","journal-title":"Biol. Res."},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib0535","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"issue":"2-3","key":"10.1016\/j.phrs.2016.11.013_bib0540","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/jsbi.2000.4274","article-title":"Review: alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity","volume":"130","author":"Varadarajan","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.phrs.2016.11.013_bib0545","first-page":"3","article-title":"Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors","volume":"2","author":"Guglielmotto","year":"2010","journal-title":"Front. Aging Neurosci."},{"issue":"45","key":"10.1016\/j.phrs.2016.11.013_bib0550","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer's-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2016.11.013_bib0555","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacool. Toxicol."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib0560","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-beta","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib0565","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuron.2006.10.035","article-title":"AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss","volume":"52","author":"Hsieh","year":"2006","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.phrs.2016.11.013_bib0570","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib0575","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","article-title":"Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5","volume":"66","author":"Renner","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2016.11.013_bib0580","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.neuroscience.2013.08.054","article-title":"Enhancement of long-term depression by soluble amyloid beta protein in rat hippocampus is mediated by metabotropic glutamate receptor and involves activation of p38MAPK, STEP and caspase-3","volume":"253","author":"Chen","year":"2013","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0585","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.neuint.2012.01.017","article-title":"Metabotropic glutamate receptors in neurodegeneration\/neuroprotection: still a hot topic?","volume":"1","author":"Caraci","year":"2012","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0590","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.nbd.2005.05.001","article-title":"Impaired metabotropic glutamate receptor\/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes","volume":"20","author":"Albasanz","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"19","key":"10.1016\/j.phrs.2016.11.013_bib0595","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1523\/JNEUROSCI.20-19-07238.2000","article-title":"Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels","volume":"20","author":"Kammermeier","year":"2000","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib0600","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0605","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1523\/JNEUROSCI.21-04-01327.2001","article-title":"Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo","volume":"21","author":"Kim","year":"2001","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"Pt. 2","key":"10.1016\/j.phrs.2016.11.013_bib0610","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1469-7793.2001.00421.x","article-title":"A characterisation of long-term depression induced by metabotropic glutamate receptor activation in the rat hippocampus in vitro","volume":"537","author":"Fitzjohn","year":"2001","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0615","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1152\/jn.00383.2005","article-title":"Differential roles for group 1 mGluR subtypes in induction and expression of chemically induced hippocampal long-term depression","volume":"95","author":"Volk","year":"2006","journal-title":"J. Neurophysiol."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib0620","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2016.11.013_bib0625","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13041-015-0107-0","article-title":"Glutamate receptors function as scaffolds for the regulation of beta-amyloid and cellular prion protein signaling complexes","volume":"8","author":"Hamilton","year":"2015","journal-title":"Mol. Brain"},{"key":"10.1016\/j.phrs.2016.11.013_bib0630","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1756-6606-7-40","article-title":"Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease","volume":"7","author":"Hamilton","year":"2014","journal-title":"Mol. Brain"},{"issue":"15","key":"10.1016\/j.phrs.2016.11.013_bib0635","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2016.11.013_bib0640","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.celrep.2016.04.077","article-title":"Chronic pharmacological mGluR5 inhibition prevents cognitive impairment and reduces pathogenesis in an alzheimer disease mouse model","volume":"15","author":"Hamilton","year":"2016","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.phrs.2016.11.013_bib0645","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1074\/jbc.M109.083915","article-title":"Beta-amyloid1-42 gene transfer model exhibits intraneuronal amyloid, gliosis, tau phosphorylation, and neuronal loss","volume":"285","author":"Rebeck","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.11.013_bib0650","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2008.12.082","article-title":"Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-beta peptide","volume":"1260","author":"Casley","year":"2009","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0655","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1124\/mol.110.067488","volume":"79","author":"Caraci","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0660","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00401-004-0820-8","article-title":"Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease","volume":"107","author":"Lee","year":"2004","journal-title":"Acta Neuropathol. (Berl.)"},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib0665","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1523\/JNEUROSCI.17-06-01891.1997","article-title":"The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling","volume":"17","author":"Bruno","year":"1997","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.013_bib0670","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1523\/JNEUROSCI.4717-09.2010","article-title":"Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals","volume":"30","author":"Kim","year":"2010","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0675","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2004.01.073","article-title":"Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039","volume":"315","author":"Yoshimizu","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.013_bib0680","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/mp.2014.87","article-title":"Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Abeta oligomer mouse","volume":"19","author":"Kim","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2016.11.013_bib0685","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brainres.2008.10.055","article-title":"The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival","volume":"1249","author":"Lee","year":"2009","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0690","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","article-title":"Regulation of neurotransmitter release by metabotropic glutamate receptors","volume":"75","author":"Cartmell","year":"2000","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0695","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0022-3565(24)38321-1","article-title":"(R, S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo","volume":"289","author":"Gasparini","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0700","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0922-4106(94)90016-7","article-title":"Activation of metabotropic glutamate receptors by L-AP4 stimulates survival of rat cerebellar granule cells in culture","volume":"288","author":"Graham","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.phrs.2016.11.013_bib0705","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1523\/JNEUROSCI.20-17-06413.2000","article-title":"Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death","volume":"20","author":"Bruno","year":"2000","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0710","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-2999(96)00358-5","article-title":"Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures","volume":"310","author":"Bruno","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib0715","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0026-895X(25)08600-6","article-title":"Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide","volume":"47","author":"Copani","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"4537","key":"10.1016\/j.phrs.2016.11.013_bib0720","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"issue":"6531","key":"10.1016\/j.phrs.2016.11.013_bib0725","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/375484a0","article-title":"Essential role of neocortical acetylcholine in spatial memory","volume":"375","author":"Winkler","year":"1995","journal-title":"Nature"},{"issue":"41","key":"10.1016\/j.phrs.2016.11.013_bib0730","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.1204-14.2014","article-title":"Abeta selectively impairs mGluR7 modulation of NMDA signaling in basal forebrain cholinergic neurons: implication in Alzheimer's disease","volume":"34","author":"Gu","year":"2014","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0735","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-8993(02)03731-9","article-title":"Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1\u201340)","volume":"958","author":"Miguel-Hidalgo","year":"2002","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0740","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.conb.2011.09.001","article-title":"New developments on the role of NMDA receptors in Alzheimer's disease","volume":"22","author":"Malinow","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"issue":"9","key":"10.1016\/j.phrs.2016.11.013_bib0745","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","article-title":"Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?","volume":"30","author":"Cicchetti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0750","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","article-title":"The neuropathological basis for depression in Parkinson's disease","volume":"15","author":"Frisina","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0755","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.brainresrev.2008.02.001","article-title":"Genetic factors involved in the pathogenesis of Parkinson's disease","volume":"58","author":"Lee","year":"2008","journal-title":"Brain Res. Rev."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib0760","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cortex.2008.11.010","article-title":"Parkinson's disease: the syndrome, the pathogenesis and pathophysiology","volume":"45","author":"Bartels","year":"2009","journal-title":"Cortex"},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib0765","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"8-9","key":"10.1016\/j.phrs.2016.11.013_bib0770","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man","volume":"103","author":"Gerlach","year":"1996","journal-title":"J. Neural. Transm. (Vienna)"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2016.11.013_bib0775","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0891-0618(01)00100-4","article-title":"Chemical neuroanatomy of the basal ganglia?normal and in Parkinson's disease","volume":"22","author":"Hornykiewicz","year":"2001","journal-title":"J. Chem. Neuroanat."},{"issue":"11","key":"10.1016\/j.phrs.2016.11.013_bib0780","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamaneurol.2015.2397","article-title":"Basal ganglia circuits as targets for neuromodulation in parkinson disease","volume":"72","author":"DeLong","year":"2015","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib0785","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.clineuro.2006.02.002","article-title":"A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy","volume":"108","author":"Benbir","year":"2006","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0790","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1353-8020(01)00023-2","article-title":"Levodopa prolongs life expectancy and is non-toxic to substantia nigra","volume":"8","author":"Rajput","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"issue":"10","key":"10.1016\/j.phrs.2016.11.013_bib0795","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd2087","article-title":"Novel pharmacological targets for the treatment of Parkinson's disease","volume":"5","author":"Schapira","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0800","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.11.013_bib0805","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/978-3-7091-0932-8_24","article-title":"Synaptic dysfunction in Parkinson's disease","volume":"970","author":"Picconi","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib0810","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1460-9568.2011.07628.x","article-title":"Molecular basis of NMDA receptor functional diversity","volume":"33","author":"Paoletti","year":"2011","journal-title":"Eur. J. Neurosci."},{"issue":"7-8","key":"10.1016\/j.phrs.2016.11.013_bib0815","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuropharm.2010.10.022","article-title":"Metabotropic glutamate receptors: from the workbench to the bedside","volume":"60","author":"Nicoletti","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.11.013_bib0820","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coph.2014.11.001","article-title":"Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease","volume":"20","author":"Amalric","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0825","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.108.150425","article-title":"Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling","volume":"330","author":"Rylander","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"13","key":"10.1016\/j.phrs.2016.11.013_bib0830","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1523\/JNEUROSCI.22-13-05669.2002","article-title":"Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism","volume":"22","author":"Breysse","year":"2002","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib0835","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/sj.npp.1300444","article-title":"Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats","volume":"29","author":"Coccurello","year":"2004","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0840","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neuropharm.2007.08.009","article-title":"Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias","volume":"54","author":"Samadi","year":"2008","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0845","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0014-2999(00)00697-X","article-title":"Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats","volume":"406","author":"Spooren","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2016.11.013_bib0850","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0028-3908(99)00082-9","article-title":"2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist","volume":"38","author":"Gasparini","year":"1999","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib0855","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00726-006-0317-y","article-title":"An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats","volume":"32","author":"Ossowska","year":"2007","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0860","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1460-9568.2005.04550.x","article-title":"Blockade of mGluR glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson's disease","volume":"23","author":"Phillips","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2016.11.013_bib0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2016.03.036","article-title":"Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: an update from the last 5 years of research","author":"Litim","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1-2","key":"10.1016\/j.phrs.2016.11.013_bib0870","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainresbull.2010.01.011","article-title":"Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease","volume":"82","author":"Ambrosi","year":"2010","journal-title":"Brain Res. Bull."},{"issue":"7","key":"10.1016\/j.phrs.2016.11.013_bib0875","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neuropharm.2009.12.024","article-title":"Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys","volume":"58","author":"Morin","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.11.013_bib0880","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neuropharm.2012.07.036","article-title":"MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates","volume":"66","author":"Morin","year":"2013","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0885","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/jpet.110.166629","article-title":"Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1 3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"333","author":"Johnston","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2016.11.013_bib0890","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2012.02.036","article-title":"Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia","volume":"683","author":"Maranis","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0895","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.parkreldis.2011.01.008","article-title":"The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in L-Dopa-treated parkinsonian monkeys","volume":"17","author":"Gregoire","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib0900","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/mds.25920","article-title":"The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model","volume":"29","author":"Bezard","year":"2014","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib0905","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mds.25859","article-title":"Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1 2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease","volume":"29","author":"Ko","year":"2014","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0910","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","article-title":"A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys","volume":"39","author":"Rylander","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.11.013_bib0915","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26659","article-title":"A phase 2A trial of the novel mGluR5-Negative allosteric modulator dipraglurant for levodopa-Induced dyskinesia in parkinson's disease","author":"Tison","year":"2016","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0920","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainresbull.2011.01.005","article-title":"Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions","volume":"84","author":"Chen","year":"2011","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0925","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2012.03.022","article-title":"Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model","volume":"102","author":"Hsieh","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Pt. 7","key":"10.1016\/j.phrs.2016.11.013_bib0930","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/brain\/awr137","article-title":"Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys","volume":"134","author":"Masilamoni","year":"2011","journal-title":"Brain: A J. Neurol."},{"issue":"13","key":"10.1016\/j.phrs.2016.11.013_bib0935","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1523\/JNEUROSCI.2702-13.2014","article-title":"Mechanisms of dopamine D1 receptor-mediated ERK1\/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5","volume":"34","author":"Fieblinger","year":"2014","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"issue":"31","key":"10.1016\/j.phrs.2016.11.013_bib0940","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1523\/JNEUROSCI.1889-07.2007","article-title":"The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration\/neuroprotection","volume":"27","author":"Corti","year":"2007","journal-title":"J. Neurosci.: Offi. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2016.11.013_bib0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2012.04.009","article-title":"mGlu3 receptor and astrocytes: partners in neuroprotection","volume":"66","author":"Durand","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.11.013_bib0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2016.04.044","article-title":"The impact of metabotropic glutamate receptors into active neurodegenerative processes: a dark side in the development of new symptomatic treatments for neurologic and psychiatric disorders","author":"Bruno","year":"2016","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib0955","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.neuroscience.2009.11.012","article-title":"Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain","volume":"165","author":"Di Liberto","year":"2010","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib0960","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/187152709789824606","article-title":"Glutamate receptors as therapeutic targets for Parkinson's disease","volume":"8","author":"Johnson","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib0965","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3233\/JPD-2011-11066","article-title":"Activation of metabotropic glutamate 4 receptors decreases L-DOPA-induced dyskinesia in a mouse model of Parkinson's disease","volume":"1","author":"Lopez","year":"2011","journal-title":"J. Parkinsons Dis."},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib0970","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jocn.2003.04.001","article-title":"Changes of mGluR4 and the effects of its specific agonist L-AP4 in a rodent model of diffuse brain injury","volume":"10","author":"Zhou","year":"2003","journal-title":"J. Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib0975","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/j.1476-5381.2012.01943.x","article-title":"Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease","volume":"166","author":"Betts","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.11.013_bib0980","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuropharm.2012.03.022","article-title":"Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia","volume":"66","author":"Bennouar","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.11.013_bib0985","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2015.02.023","article-title":"Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: comparison between a positive allosteric modulator and an orthosteric agonist","volume":"95","author":"Iderberg","year":"2015","journal-title":"Neuropharmacology"},{"issue":"21","key":"10.1016\/j.phrs.2016.11.013_bib0990","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1021\/jm200956q","volume":"54","author":"Jones","year":"2011","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib0995","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1124\/jpet.112.196063","article-title":"A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease","volume":"343","author":"Le Poul","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"51","key":"10.1016\/j.phrs.2016.11.013_bib1000","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1073\/pnas.0508063102","article-title":"A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo","volume":"102","author":"Mitsukawa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4b","key":"10.1016\/j.phrs.2016.11.013_bib1005","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1476-5381.2011.01515.x","article-title":"Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata","volume":"65","author":"Broadstock","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib1010","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.109.162115","article-title":"Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease","volume":"332","author":"Greco","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib1015","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S1734-1140(13)71477-4","article-title":"Contribution of the mGluR7 receptor to antiparkinsonian-like effects in rats: a behavioral study with the selective agonist AMN082","volume":"65","author":"Konieczny","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib1020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0028-3908(00)00169-6","article-title":"(S)-3 4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord","volume":"40","author":"Thomas","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.11.013_bib1025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuropharm.2012.03.029","article-title":"The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease","volume":"66","author":"Johnson","year":"2013","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib1030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"Group","year":"1993","journal-title":"Cell"},{"issue":"Suppl. 2","key":"10.1016\/j.phrs.2016.11.013_bib1035","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1590\/1516-4446-2013-1157","article-title":"Animal models of neurodegenerative diseases","volume":"35","author":"Ribeiro","year":"2013","journal-title":"Revista brasileira de psiquiatria"},{"issue":"10","key":"10.1016\/j.phrs.2016.11.013_bib1040","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington's disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib1045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet.: TIG"},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib1050","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0896-6273(93)90127-D","article-title":"Huntington's disease gene (IT15) is widely expressed in human and rat tissues","volume":"11","author":"Li","year":"1993","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib1055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng1193-259","article-title":"Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues","volume":"5","author":"Strong","year":"1993","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib1060","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J. Neurochem."},{"issue":"1-2","key":"10.1016\/j.phrs.2016.11.013_bib1065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2004.06.005","article-title":"The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease","volume":"1019","author":"Schiefer","year":"2004","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib1070","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"issue":"6066","key":"10.1016\/j.phrs.2016.11.013_bib1075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington\u2019s disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib1080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-4886(90)90014-J","article-title":"A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon","volume":"108","author":"Hantraye","year":"1990","journal-title":"Exp. Neurol."},{"issue":"27","key":"10.1016\/j.phrs.2016.11.013_bib1085","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-d-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib1090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/exnr.1999.7092","article-title":"Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease","volume":"158","author":"Calabresi","year":"1999","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.phrs.2016.11.013_bib1095","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington\u2019s disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib1100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1 4,5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib1105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1523\/JNEUROSCI.4974-09.2010","article-title":"Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington\u2019s disease","volume":"30","author":"Ribeiro","year":"2010","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib1110","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/hmg\/ddt598","article-title":"Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease","volume":"23","author":"Ribeiro","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib1115","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.bjp.0706219","article-title":"Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors","volume":"145","author":"Lea","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2016.11.013_bib1120","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1046\/j.0953-816x.2001.01541.x","article-title":"An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors","volume":"13","author":"Bruno","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"41","key":"10.1016\/j.phrs.2016.11.013_bib1125","doi-asserted-by":"crossref","first-page":"34840","DOI":"10.1074\/jbc.M504508200","article-title":"Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin","volume":"280","author":"Anborgh","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2016.11.013_bib1130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuropharm.2005.04.029","article-title":"Group I metabotropic glutamate receptors reduce excitotoxic injury and may facilitate neurogenesis","volume":"49","author":"Baskys","year":"2005","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib1135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0169-328X(03)00321-8","article-title":"Changes in hippocampal gene expression after neuroprotective activation of group I metabotropic glutamate receptors","volume":"117","author":"Blaabjerg","year":"2003","journal-title":"Brain. Res. Mol. Brain Res."},{"issue":"6","key":"10.1016\/j.phrs.2016.11.013_bib1140","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib1145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mcn.2008.09.007","article-title":"Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments","volume":"40","author":"Warby","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib1150","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bph.12164","article-title":"Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington\u2019s disease","volume":"169","author":"Doria","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib1155","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11064-011-0691-z","article-title":"Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK\/ERK pathway","volume":"37","author":"Chen","year":"2012","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.phrs.2016.11.013_bib1160","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s13311-014-0298-6","article-title":"Novel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury","volume":"11","author":"Loane","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.phrs.2016.11.013_bib1165","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/jpet.105.090308","article-title":"Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes","volume":"15","author":"Zhang","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.11.013_bib1170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2014.08.021","article-title":"The mGluR5 positive allosteric modulator CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington\u2019s disease","volume":"73","author":"Doria","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2016.11.013_bib1175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0301-0082(03)00019-4","article-title":"Neurotrophin secretion: current facts and future prospects","volume":"69","author":"Lessmann","year":"2003","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib1180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/35049004","article-title":"Neurotrophins as synaptic modulators","volume":"2","author":"Poo","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"5529","key":"10.1016\/j.phrs.2016.11.013_bib1185","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib1190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib1195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib1200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol."},{"issue":"35","key":"10.1016\/j.phrs.2016.11.013_bib1205","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2016.11.013_bib1210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"issue":"44","key":"10.1016\/j.phrs.2016.11.013_bib1215","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib1220","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1326-6-71","article-title":"Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction","volume":"6","author":"Giralt","year":"2011","journal-title":"Mol. Neurodegen."},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib1225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s007260070040","article-title":"Cell-type specificity of mGluR activation in striatal neuronal subtypes","volume":"19","author":"Pisani","year":"2000","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.013_bib1230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/(SICI)1096-9861(19980105)390:1<5::AID-CNE2>3.0.CO;2-6","article-title":"Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2\/3 in the rat basal ganglia","volume":"390","author":"Testa","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.phrs.2016.11.013_bib1235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2012.07.026","article-title":"BDNF may play a differential role in the protective effect of the mGluR2\/3 agonist LY379268 on striatal projection neurons in R6\/2 Huntington\u2019s disease mice","volume":"1473","author":"Reiner","year":"2012","journal-title":"Brain Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816312130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816312130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T15:14:04Z","timestamp":1749741244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816312130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":247,"alternative-id":["S1043661816312130"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.013","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabotropic glutamate receptors and neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}